Search research articles
Contact Us
Filters
Showing results (601-610 of 644) with videos related to
Page
of 65
Sort By:
Obstetrics and Gynecology
|
December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer
Britt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Plos Biology
|
March 20, 2014
Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor
Diego M Presman, M Florencia Ogara, Martín Stortz, et al.
Gynecologic Oncology
|
December 1, 2015
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3)
Ronald D Alvarez, Warner K Huh, Sejong Bae, et al.
Oncotarget
|
November 27, 2016
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Genomic mosaicism reveals developmental organization of trunk neural crest-derived ganglia
Keng Ioi Vong, Yanina D Alvarez, Geoffroy Noel, et al.
Critical Reviews in Oncology/Hematology
|
October 9, 2020
International liquid biopsy standardization alliance white paper
Dana Connors, Jeff Allen, J D Alvarez, et al.
Gynecologic Oncology
|
July 16, 2015
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice
David E Cohn, Laura J Havrilesky, Kathryn Osann, et al.
Gene Therapy
|
March 16, 2002
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv
W O Arafat, J Gómez-Navarro, D J Buchsbaum, et al.
Oncotarget
|
May 4, 2018
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Gynecologic Oncology
|
March 17, 2018
Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP)
Emily M Ko, Laura J Havrilesky, Ronald D Alvarez, et al.
Page
of 65
Search research articles
Search
Showing results (601-610 of 644) with videos related to
Sort By:
Page
of 65
Obstetrics and Gynecology
|
December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer
Britt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Plos Biology
|
March 20, 2014
Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor
Diego M Presman, M Florencia Ogara, Martín Stortz, et al.
Gynecologic Oncology
|
December 1, 2015
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3)
Ronald D Alvarez, Warner K Huh, Sejong Bae, et al.
Oncotarget
|
November 27, 2016
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Genomic mosaicism reveals developmental organization of trunk neural crest-derived ganglia
Keng Ioi Vong, Yanina D Alvarez, Geoffroy Noel, et al.
Critical Reviews in Oncology/Hematology
|
October 9, 2020
International liquid biopsy standardization alliance white paper
Dana Connors, Jeff Allen, J D Alvarez, et al.
Gynecologic Oncology
|
July 16, 2015
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice
David E Cohn, Laura J Havrilesky, Kathryn Osann, et al.
Gene Therapy
|
March 16, 2002
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv
W O Arafat, J Gómez-Navarro, D J Buchsbaum, et al.
Oncotarget
|
May 4, 2018
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Gynecologic Oncology
|
March 17, 2018
Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP)
Emily M Ko, Laura J Havrilesky, Ronald D Alvarez, et al.
Page
of 65